-
1
المؤلفون: Michal Stark, Elisa Giovannetti, Gerrit Jansen, Larry H. Matherly, Maria Gemelli, Godefridus J. Peters, Erik Thunnissen, Ittai B. Muller, Zhanjun Hou, P. A. Zucali, E. A. Struys, Niccola Funel, M. Perrino, Yehuda G. Assaraf
المساهمون: Medical oncology laboratory, CCA - Cancer biology and immunology, Pathology, Clinical chemistry, AGEM - Inborn errors of metabolism, AGEM - Endocrinology, metabolism and nutrition, Rheumatology, AGEM - Digestive immunity
المصدر: Annals of Oncology, 28(11), 2725-2732. Oxford University Press
Giovannetti, E, Zucali, P A, Assaraf, Y G, Funel, N, Gemelli, M, Stark, M, Thunnissen, E, Hou, Z, Muller, I B, Struys, E A, Perrino, M, Jansen, G, Matherly, L H & Peters, G J 2017, ' Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma : Clinical evidence and new pharmacological tools ', Annals of Oncology, vol. 28, no. 11, pp. 2725-2732 . https://doi.org/10.1093/annonc/mdx499Testمصطلحات موضوعية: Male, Mesothelioma, 0301 basic medicine, Oncology, Thymidylate synthase, Immunoenzyme Techniques, Reduced Folate Carrier Protein, chemistry.chemical_compound, 0302 clinical medicine, Tumor Cells, Cultured, Aged, 80 and over, biology, Hematology, Methylation, Middle Aged, Prognosis, Survival Rate, Pemetrexed, 030220 oncology & carcinogenesis, Antifolate, Immunohistochemistry, Female, Proton-Coupled Folate Transporter, medicine.drug, Adult, medicine.medical_specialty, Pleural Neoplasms, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Humans, Gene silencing, Survival rate, Aged, Cell Proliferation, business.industry, Original Articles, Thymidylate Synthase, medicine.disease, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, biology.protein, Folic Acid Antagonists, business, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ccf6187f967e64fb83a9f2dcd466830Test
https://doi.org/10.1093/annonc/mdx499Test -
2
المؤلفون: Carlotta Granchi, Elisa Giovannetti, Amir Avan, Babette Aicher, Daniela Massihnia, Mina Maftouh, Leticia G. Leon, Rajiv S. Raktoe, Anne van Krieken, Niccola Funel, Filippo Minutolo, Antonio Russo, Ugo Boggi, Godefridus J. Peters
المساهمون: Massihnia, D., Avan, A., Funel, N., Maftouh, M., Van Krieken, A., Granchi, C., Raktoe, R., Boggi, U., Aicher, B., Minutolo, F., Russo, A., Leon, L., Peters, G., Giovannetti, E., CCA - Cancer biology and immunology, AGEM - Digestive immunity, Medical oncology laboratory, AGEM - Re-generation and cancer of the digestive system
المصدر: Massihnia, D, Avan, A, Funel, N, Maftouh, M, Van Krieken, A, Granchi, C, Raktoe, R, Boggi, U, Aicher, B, Minutolo, F, Russo, A, Leon, L G, Peters, G J & Giovannetti, E 2017, ' Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer ', Journal of Hematology and Oncology, vol. 10, no. 1, 9 . https://doi.org/10.1186/s13045-016-0371-1Test
Journal of Hematology & Oncology
Journal of Hematology and Oncology, 10(1):9. BioMed Central
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-17 (2017)مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Biopsy, AKT1, Apoptosis, Akt, Gemcitabine, Pancreatic ductal adenocarcinoma, Synergism, Hematology, Molecular Biology, Deoxycytidine, 0302 clinical medicine, Cell Movement, Tumor Cells, Cultured, Glucose Transporter Type 1, medicine.diagnostic_test, Chemistry, Cell Cycle, Pancreatic Neoplasm, Drug Synergism, lcsh:Diseases of the blood and blood-forming organs, Cell cycle, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Aged, Carcinoma, Pancreatic Ductal, Female, Humans, Pancreatic Neoplasms, Phosphoproteins, Proto-Oncogene Proteins c-akt, RNA, Messenger, Spheroids, Cellular, 030220 oncology & carcinogenesis, Phosphoprotein, medicine.drug, Human, medicine.medical_specialty, Prognosi, lcsh:RC254-282, Flow cytometry, 03 medical and health sciences, Internal medicine, Pancreatic cancer, medicine, Protein kinase B, PI3K/AKT/mTOR pathway, lcsh:RC633-647.5, Research, Apoptosi, medicine.disease, 030104 developmental biology, Cancer cell, Cancer research
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0527d043c396c119ac955e1ab571ea8Test
https://research.vumc.nl/en/publications/e3915272-5f2e-4b5f-a149-4af093da963cTest -
3
المساهمون: Medical oncology laboratory, CCA - Innovative therapy
المصدر: Journal of Cancer Research and Clinical Oncology, 141(7), 1189-1194. Springer Verlag
Vasile, E, Tibaldi, C, Leon, G L, D'Incecco, A & Giovannetti, E 2015, ' Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients ', Journal of Cancer Research and Clinical Oncology, vol. 141, no. 7, pp. 1189-1194 . https://doi.org/10.1007/s00432-014-1880-3Testمصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, CYP1B1, medicine.medical_treatment, non-small cell lung cancer (NSCLC), Antineoplastic Agents, Single-nucleotide polymorphism, Docetaxel, Polymorphism, Single Nucleotide, Biomarkers, Pharmacological, Polymorphism (computer science), Carcinoma, Non-Small-Cell Lung, Internal medicine, Tumor Cells, Cultured, medicine, Carcinoma, Humans, neoplasms, Genetic Association Studies, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, Hematology, business.industry, General Medicine, Middle Aged, Prognosis, medicine.disease, body regions, Treatment Outcome, Chemotherapy, Adjuvant, Cytochrome P-450 CYP1B1, Female, Taxoids, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5595da0c67b8409b2e8a1b7b1b23d1Test
https://research.vumc.nl/en/publications/96018efa-575a-443a-b58a-d1486c35ebb8Test -
4
المؤلفون: Alfredo Falcone, Ugo Boggi, G.J. Peters, Franco Mosca, Gerrit A. Meijer, Elisa Giovannetti, Niccola Funel, A.G. van der Velde, S. Caponi, Libero Santarpia, Geert Kazemier, Adam E Frampton, Henk M.W. Verheul, Enrico Vasile, Long R. Jiao, N De Lio
المساهمون: Pathology, Surgery, Medical oncology, Medical oncology laboratory, CCA - Disease profiling
المصدر: Annals of Oncology, 24(3), 734-741. Oxford University Press
Caponi, S, Funel, N, Frampton, A E, Mosca, F, Santarpia, L, van der Velde, A G, Jiao, L R, De Lio, N, Falcone, A, Kazemier, G, Meijer, G A, Verheul, H M W, Vasile, E, Peters, G J, Boggi, U & Giovannetti, E 2013, ' The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms ', Annals of Oncology, vol. 24, no. 3, pp. 734-741 . https://doi.org/10.1093/annonc/mds513Test
Università di Pisa-IRISمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Pathology, Multivariate analysis, Kaplan-Meier Estimate, Gastroenterology, Disease-Free Survival, miR-155, Internal medicine, medicine, Carcinoma, Humans, Neoplasm Invasiveness, Prospective cohort study, Aged, Proportional Hazards Models, Aged, 80 and over, Proportional hazards model, business.industry, Hazard ratio, Hematology, Middle Aged, medicine.disease, Adenocarcinoma, Mucinous, Confidence interval, Pancreatic Neoplasms, Adenocarcinoma, Papillary, MicroRNAs, Oncology, Lymphatic Metastasis, Multivariate Analysis, Adenocarcinoma, Female, business, Carcinoma, Pancreatic Ductal
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bae444b08d57f79eb53f15a00973070Test
https://research.vumc.nl/en/publications/549079eb-2b09-49bf-b086-a35af48aefbfTest